Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760506
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic HealthApplied Science & Performance InstituteNot Yet RecruitingNot Applicable
NCT07760506Not Yet Recruiting
Not Applicable
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting...Applied Science & Perform...
NCT07761572
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific ABNot Yet RecruitingPhase 2
NCT07761572Not Yet Recruiting
Phase 2
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific AB
NCT07761299
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical LtdNot Yet Recruiting
NCT07761299Not Yet Recruiting
—
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical Ltd
NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted BronchoscopyIntuitive SurgicalNot Yet RecruitingPhase 4
NCT07761351Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-...Intuitive Surgical
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
NCT07761767
Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid ArthritisAssiut UniversityNot Yet RecruitingNot Applicable
NCT07761767Not Yet Recruiting
Not Applicable
Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid Art...Assiut University
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761494
Risk Factors Favourable to Promote Intra- and Postsurgical Complications Accompanying Microscrew Insertion for Distalisation of Maxillary DentitionWroclaw Medical UniversityCompletedNot Applicable
NCT07761494Completed
Not Applicable
Risk Factors Favourable to Promote Intra- and Postsurgical Complications Accompa...Wroclaw Medical Universit...
NCT07760051
Effect of Agent-assisted, LLM-assisted and Traditional Workflows on Physician Admission DiagnosisSecond Affiliated Hospital, Zhejiang University, School of MedicineNot Yet RecruitingNot Applicable
NCT07760051Not Yet Recruiting
Not Applicable
Effect of Agent-assisted, LLM-assisted and Traditional Workflows on Physician Ad...Second Affiliated Hospita...
NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07761923Not Yet Recruiting
Not Applicable
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska Institutet
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759427
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular TachycardiaUniversity Hospitals Coventry and Warwickshire NHS TrustRecruitingNot Applicable
NCT07759427Recruiting
Not Applicable
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tac...University Hospitals Cove...
NCT07760402
Effects Of Propofol And Sevoflurane On Plasma Mirna Levels İn Living Kidney DonorsUniversity of GaziantepRecruitingNot Applicable
NCT07760402Recruiting
Not Applicable
Effects Of Propofol And Sevoflurane On Plasma Mirna Levels İn Living Kidney Dono...University of Gaziantep
NCT07759791
Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following StrokeBruyère Health Research Institute.RecruitingNot Applicable
NCT07759791Recruiting
Not Applicable
Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Ac...Bruyère Health Research I...
NCT07761793
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman AlghoulNot Yet RecruitingNot Applicable
NCT07761793Not Yet Recruiting
Not Applicable
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman Alghoul
NCT07759830
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Menopausal Hot Flushes and Night Sweats.Queen's University, BelfastCompletedNot Applicable
NCT07759830Completed
Not Applicable
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Meno...Queen's University, Belfa...
NCT07759401
Food As Medicine to Reduce CKD Burden in Health Disparity PopulationsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not Yet RecruitingNot Applicable
NCT07759401Not Yet Recruiting
Not Applicable
Food As Medicine to Reduce CKD Burden in Health Disparity PopulationsNational Institute of Dia...
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Recruiting3 (15%)
not_applicable14 (70%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 41 (5%)